Low-Level Viremia Is Associated With Cumulative Adherence to Antiretroviral Therapy in Persons With HIV

被引:19
作者
Castillo-Mancilla, Jose R. [1 ]
Morrow, Mary [2 ]
Coyle, Ryan P. [1 ]
Coleman, Stacey S. [3 ]
Zheng, Jia-Hua [4 ,5 ]
Ellison, Lucas [4 ,5 ]
Bushman, Lane R. [4 ,5 ]
Kiser, Jennifer J. [4 ,5 ]
Anderson, Peter L. [4 ,5 ]
MaWhinney, Samantha [2 ]
机构
[1] Univ Colorado AMC, Sch Med, Div Infect Dis, Aurora, CO USA
[2] Colorado Sch Publ Hlth, Dept Biostat & Bioinformat, Aurora, CO USA
[3] Univ Colorado Hosp, Aurora, CO USA
[4] Univ Colorado AMC, Skaggs Sch Pharm & Pharmaceut Sci, Colorado Antiviral Pharmacol Lab, Aurora, CO USA
[5] Univ Colorado AMC, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA
来源
OPEN FORUM INFECTIOUS DISEASES | 2021年 / 8卷 / 09期
基金
美国国家卫生研究院;
关键词
low-level viremia; adherence; dried blood spots; tenofovir diphosphate; antiretroviral therapy; TENOFOVIR-DIPHOSPHATE; EMTRICITABINE; BLIPS;
D O I
10.1093/ofid/ofab463
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The drivers of low-level viremia (LLV) between 20 and 200 copies/mL remain unclear. In 1042 person-visits from 497 persons with HIV on tenofovir disoproxil fumarate-containing antiretroviral therapy (ART), the association between LLV and cumulative antiretroviral adherence (quantified using tenofovir diphosphate [TFV-DP] in dried blood spots) was assessed. Lower TFV-DP levels were associated with higher odds of LLV. As TFV-DP (fmol/punch) categories decreased from >1650 to 800-1650; 800-1650 to <800; and >1650 to <800, the adjusted odds ratios for LLV vs HIV VL <20 copies/mL were 2.0 (95% CI, 1.2-3.1), 2.4 (95% CI, 1.1-5.0), and 4.6 (95% CI, 2.2-9.9), respectively. This suggests that adherence could impact LLV.
引用
收藏
页数:5
相关论文
共 23 条
  • [1] Tenofovir Diphosphate in Dried Blood Spots Is Strongly Associated With Viral Suppression in Individuals With Human Immunodeficiency Virus Infections
    Castillo-Mancilla, Jose R.
    Morrow, Mary
    Coyle, Ryan P.
    Coleman, Stacey S.
    Gardner, Edward M.
    Zheng, Jia-Hua
    Ellison, Lucas
    Bushman, Lane R.
    Kiser, Jennifer J.
    Mawhinney, Samantha
    Anderson, Peter L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2019, 68 (08) : 1335 - 1342
  • [2] Castillo-Mancilla JR, 2013, AIDS RES HUM RETROV, V29, P384, DOI [10.1089/aid.2012.0089, 10.1089/AID.2012.0089]
  • [3] Antiretroviral Therapy for the Prevention of HIV-1 Transmission
    Cohen, M. S.
    Chen, Y. Q.
    McCauley, M.
    Gamble, T.
    Hosseinipour, M. C.
    Kumarasamy, N.
    Hakim, J. G.
    Kumwenda, J.
    Grinsztejn, B.
    Pilotto, J. H. S.
    Godbole, S. V.
    Chariyalertsak, S.
    Santos, B. R.
    Mayer, K. H.
    Hoffman, I. F.
    Eshleman, S. H.
    Piwowar-Manning, E.
    Cottle, L.
    Zhang, X. C.
    Makhema, J.
    Mills, L. A.
    Panchia, R.
    Faesen, S.
    Eron, J.
    Gallant, J.
    Havlir, D.
    Swindells, S.
    Elharrar, V.
    Burns, D.
    Taha, T. E.
    Nielsen-Saines, K.
    Celentano, D. D.
    Essex, M.
    Hudelson, S. E.
    Redd, A. D.
    Fleming, T. R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (09) : 830 - 839
  • [4] Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy
    Fleming, Julia
    Mathews, W. Christopher
    Rutstein, Richard M.
    Aberg, Judith
    Somboonwit, Charurut
    Cheever, Laura W.
    Berry, Stephen A.
    Gebo, Kelly A.
    Moore, Richard D.
    [J]. AIDS, 2019, 33 (13) : 2005 - 2012
  • [5] Cumulative Antiretroviral Exposure Measured in Hair Is Not Associated With Measures of HIV Persistence or Inflammation Among Individuals on Suppressive ART
    Gandhi, Monica
    Gandhi, Rajesh T.
    Stefanescu, Andrei
    Bosch, Ronald J.
    Cyktor, Joshua C.
    Horng, Howard
    Louie, Alexander
    Nhi Phung
    Eron, Joseph J.
    Hogg, Evelyn
    Macatangay, Bernard J. C.
    Hensel, Christopher
    Fletcher, Courtney V.
    Mellors, John W.
    McMahon, Deborah K.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (02) : 234 - 238
  • [6] Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy:: frequency, predictors and outcome
    Garcia-Gasco, Pilar
    Maida, Ivana
    Blanco, Francisco
    Barreiro, Pablo
    Martin-Carbonero, Luz
    Vispo, Eugenia
    Gonzalez-Lahoz, Juan
    Soriano, Vincent
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (03) : 699 - 704
  • [7] Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale
    Giordano, TP
    Guzman, D
    Clark, R
    Charlebois, ED
    Bangsberg, DR
    [J]. HIV CLINICAL TRIALS, 2004, 5 (02): : 74 - 79
  • [8] Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
    Konstantopoulos, Christina
    Ribaudo, Heather
    Ragland, Kathleen
    Bangsberg, David R.
    Li, Jonathan Z.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2015, 2 (01):
  • [9] Kristofich M, THER ADV INFECT DIS, V8
  • [10] Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation
    Laprise, Claudie
    de Pokomandy, Alexandra
    Baril, Jean-Guy
    Dufresne, Serge
    Trottier, Helen
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 57 (10) : 1489 - 1496